Teva’s injectable asthma biologic approved by FDA – The Pharmaceutical Journal

Teva's injectable asthma biologic approved by FDA
The Pharmaceutical Journal
The biologic treatment, which is given as a four-weekly infusion alongside other drugs, is indicated to help those patients with severe asthma who still have serious asthma attacks despite being on regular medication. It is expected to be launched in

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.